Toric implantable collamer lens offers good results

Article

Implanting the Toric Implantable Collamer Lens (TICL; STAAR Surgical) to correct various degrees of myopia and compound myopic astigmatism, produces predictable refractive results.

Implanting the Toric Implantable Collamer Lens (TICL; STAAR Surgical) to correct various degrees of myopia and compound myopic astigmatism, produces predictable refractive results, according to Daniel Elies from the Instut Oftalmologic Integral, Barcelona, Spain.

The TICL was implanted into 63 eyes of 36 patients with myopic compound astigmatism. The mean preoperative spherical equivalent (SE) was -10.58±3.41 D and the mean preoperative astigmatism was -3.59±1.38 D. The standard recommendations from the manufacturer regarding preoperative measurements, nomogram and implantation technique were followed.

Following implantation of the TICL, mean SE was -10.26 D (p<0.0001) and mean cylinder was -2.87 D (p<0.0001). Holladay analysis of astigmatism showed a large reduction.

At one-year follow-up, 82.5% of eyes had SE within ±0.50 D and 68.3± had an uncorrected visual acuity (UCVA) equal to or better than the preoperative best corrected visual acuity (BCVA). Approximately 60% of eyes gained at least one line of best spectacle corrected visual acuity (BSCVA). At two weeks postoperatively, four eyes had an intraocular pressure (IOP) over 21 mmHg due to steroids. Two eyes (of the same patient) developed adenoviric KCT and five eyes showed tilted IOL, one of which required repositioning.

Overall, Dr Elies concluded that the TICL offers predictable and effective refractive results.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.